SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 6,865.17 |
| Enterprise Value ($M) | 8,215.00 |
| Book Value ($M) | 452.70 |
| Book Value / Share | 3.56 |
| Price / Book | 15.16 |
| NCAV ($M) | -538.35 |
| NCAV / Share | -4.23 |
| Price / NCAV | -12.75 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.20 |
| Return on Assets (ROA) | 0.21 |
| Return on Equity (ROE) | 1.58 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.15 |
| Current Ratio | 10.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,126.98 |
| Assets | 2,118.03 |
| Liabilities | 1,665.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Artisan Partners Limited Partnership | 2.50 | -53.16 | |
| 13G | State Street Corp | 5.20 | ||
| 13G/A | Vanguard Group Inc | 10.04 | -1.99 | |
| 13G/A | Invesco Ltd. | 2.10 | -59.98 | |
| 13G/A | BlackRock, Inc. | 14.10 | -2.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,301,282 | 6,697,445 | 19.43 | |
| 696,135 | 2,854,938 | 24.38 | |
| 200,133 | 635,063 | 31.51 | |
| 452,454 | 1,282,367 | 35.28 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GILD – Gilead Sciences, Inc. | GLUE – Monte Rosa Therapeutics, Inc. |
| GOSS – Gossamer Bio, Inc. | HLVX – HilleVax, Inc. |
| HOWL – Werewolf Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io